GAMOPHEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gamophen, and when can generic versions of Gamophen launch?
Gamophen is a drug marketed by Arbrook and is included in one NDA.
The generic ingredient in GAMOPHEN is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
Summary for GAMOPHEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 3,372 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GAMOPHEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GAMOPHEN
US Patents and Regulatory Information for GAMOPHEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbrook | GAMOPHEN | hexachlorophene | SOAP;TOPICAL | 006270-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |